Skip to main content
SpringerLink
Log in

Care of the Patient Who Misuses Drugs

  • Living reference work entry
  • First Online:
Family Medicine

  • 1588 Accesses

Abstract

According to the 2013 National Survey on Drug Use and Health (NSDUH), an estimated 24.6 million Americans aged 12 or older were current illicit drug users [1]. This represents nearly 10 % of the population aged 12 and older, and primary care providers encounter these patients on a regular basis. Unfortunately, primary care physicians may not feel well prepared to deal with substance abuse due to lack of training, discomfort with the subject, time constraints, and lack of confidence in available treatments [2]. However, patients with substance use disorder can be well cared for using a chronic disease framework that is familiar to most primary care providers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Substance Abuse and Mental Health Services Administration. Results from the 2013 National survey on drug use and health: summary of national findings, NSDUH series H-48, HHS publication no. (SMA) 14–4863. Rockville: Substance Abuse and Mental Health Services Administration; 2014.

    Google Scholar 

  2. The National Center on Addiction and Substance Abuse at Columbia University. Missed opportunity: national survey of primary care physicians and patients on substance abuse. 2000. http://www.casacolumbia.org/addiction-research/reports/national-survey-primary-care-physicians-patients-substance-abuse. Accessed 23 Feb 2015.

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington: American Psychiatric Association; 2013.

    Book  Google Scholar 

  4. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284(13):1689–95.

    Article  CAS  PubMed  Google Scholar 

  5. U.S. Preventative Services Task Force. Drug use, illicit: screening. 2008. http://www.uspreventiveservicestaskforce.org/uspstf/uspsdrug.htm. Accessed 23 Feb 2015.

  6. Shapiro B, Coffa D, McCance-Katz EF. A primary care approach to substance misuse. Am Fam Physician. 2013;88(2):113–21.

    PubMed  Google Scholar 

  7. Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7–30.

    Article  PubMed  Google Scholar 

  8. Zgierska A, Amaza IP, Brown RL, Mundt M, Fleming MF. Unhealthy drug use: how to screen, when to intervene. J Fam Pract. 2014;63(9):524–30.

    PubMed  Google Scholar 

  9. National Institute on Drug Abuse. Resource guide: screening for drug use in general medical settings. 2010. http://www.drugabuse.gov/publications/resource-guide-screening-drug-use-in-general-medical-settings/nida-quick-screen. Accessed 23 Feb 2015.

  10. Smith PC, Schmidt SM, Allensworth-Davies D, et al. A single-question screening test for drug use in primary care. Arch Int Med. 2010;170(13):1155–60.

    Article  Google Scholar 

  11. Dhalla S, Kopec JA. The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med. 2007;30:33–41.

    PubMed  Google Scholar 

  12. Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005;77(1):49–59.

    Article  PubMed  Google Scholar 

  13. Saitz R, Palfai TP, Cheng DM, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–13.

    Article  PubMed  Google Scholar 

  14. National Institute on Drug Abuse. Drugfacts: nationwide trends. http://www.drugabuse.gov/publications/drugfacts/nationwide-trends. Accessed 23 Feb 2015.

  15. Karila L, Petit A, Lowenstein W, et al. Diagnosis and consequences of cocaine addiction. Curr Med Chem. 2012;19:5612–8.

    Article  CAS  PubMed  Google Scholar 

  16. University of Maryland. Amphetamines. 2013. http://www.cesar.umd.edu/cesar/drugs/amphetamines.asp. Accessed 20 Feb 2015.

  17. Finkel JB, Marhefka GD. Rethinking cocaine-associated chest pain and acute coronary syndromes. Mayo Clin Proc. 2011;86(12):1198–207.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Cain MA, Bornick P, Whiteman V. The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy. Clin Obstet Gynecol. 2013;56(1):124–32.

    Article  PubMed  Google Scholar 

  19. Kaplan HI, Sadock BJ. Concise textbook of clinical psychiatry. 7th ed. Baltimore: Williams and Wilkins; 1996.

    Google Scholar 

  20. van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathologtical gambling. Curr Drug Abuse Rev. 2012;5:3–31.

    Article  PubMed  Google Scholar 

  21. Pani PP, Trogu E, Vecchi S, Amato L. Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst Rev. 2011; 12:CD002950.

    Google Scholar 

  22. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN report: highlights of the 2011 drug abuse warning network (DAWN) findings on drug-related emergency department visits. Rockville.

    Google Scholar 

  23. Paulozzi JL, Weisler RH, Patkar AA. A national epidemic of unintentional prescriptions opioid overdose deaths: how physicians can help control it [published online ahead of print 19 Apr 2011]. doi:10.4088/JCP.10com06560.

    Google Scholar 

  24. SAMHSA. Opioids. 2015. http://www.samhsa.gov/atod/opioids. Accessed 26 June 2015.

  25. Office of National Drug Control Policy. What America’s users spend on illegal drugs, 2000–2006. Washington, DC: Executive Office of the President; 2012. http://www.whitehouse.gov/sites/default/files/page/files/wausid_report_final_1.pdf. Accessed 20 Feb 2015.

  26. National Institute on Drug Abuse. Drugfacts: heroin. 2014. http://www.drugabuse.gov/publications/drugfacts/heroin. Accessed 15 Jan 2015.

  27. Dixon P. Managing acute heroin overdose. Emerg Nurse. 2007;15(2):30–5.

    Article  PubMed  Google Scholar 

  28. Alcorn T. America embraces treatment for opioid drug overdose. Lancet. 2014;383(9933):1957–8.

    Article  PubMed  Google Scholar 

  29. Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2–guidance. Pain Physician. 2012;15(3 Suppl):S67–116.

    PubMed  Google Scholar 

  30. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Canada: National Opioid Use Guideline Group (NOUGG); 2010. http://nationalpaincentre.mcmaster.ca/opioid/. Accessed 12 Dec 2014.

  31. Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O’Connor PG. Primary care–based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA Intern Med. 2014;174(12):1947–54.

    Article  PubMed  Google Scholar 

  32. Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci. 2007;9(4):455–70.

    PubMed Central  PubMed  Google Scholar 

  33. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207. doi:10.1002/14651858.CD002207.pub4.

    Google Scholar 

  34. Haddad MS, Zelenev A, Altice FL. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers [published online ahead of print 31 Dec 2014]. J Urban Health. doi:10.1007/s11524-014-9924-1.

    Google Scholar 

  35. American College of Obstetricians and Gynecologists. Opioid abuse, dependence, and addiction in pregnancy. Committee opinion no. 524. Obstet Gynecol. 2012;119:1070–6.

    Article  Google Scholar 

  36. Stanhope TJ, Gill LA, Rose C. Chronic opioid use during pregnancy: maternal and fetal implications. Clin Perinatol. 2013;40(3):337–50.

    Article  PubMed  Google Scholar 

  37. Woody G. Antagonist models for treating persons with substance use disorders [published online ahead of print 3 Sept 2014]. Curr Psychiatry Rep. 16:489. doi:10.1007/s11920-014-0489-1.

    Google Scholar 

  38. University of Maryland. Marijuana. 2013. http://www.cesar.umd.edu/cesar/drugs/marijuana.asp. Accessed 15 Jan 2015.

  39. SAMHSA. Emergency department visits linked to ‘synthetic marijuana’ products rising. 2014. http://www.samhsa.gov/newsroom/press-announcements/201410161215. Accessed 16 Feb 2015.

  40. Budney AJ, Ruffman R, Stephens RS, Walker D. Marijuana dependence and its treatment. Addict Sci Clin Pract. 2007;4(1):4–16.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Lader M. Benzodiazepines revisited – will we ever learn? Addiction. 2011;106(12):2086–109.

    Article  PubMed  Google Scholar 

  42. Billioti de Gage S, Moride Y, Ducruet T, et al. Benzodiazepine use and risk of Alzheimer’s disease: case–control study. BMJ. 2014;349:g5205.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Gudin JA, Mogali S, Jones JD, Comer SD. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use. Postgrad Med. 2013;125(4):115–30.

    Article  PubMed Central  PubMed  Google Scholar 

  44. American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. 2nd ed. 2009. http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf. Accessed 10 Dec 2014.

  45. Petursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89:1455–9.

    Article  CAS  PubMed  Google Scholar 

  46. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Phys. 2003;68(5):869–74.

    Google Scholar 

  47. Shultz JE. The integration of medical management with recovery. J Psychoactive Drugs. 1997;29(3):233–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, UNC – Chapel Hill, 101 Manning Drive, 27514, Chapel Hill, NC, USA

    Fedoriw Kelly Bossenbroek

Authors
  1. Fedoriw Kelly Bossenbroek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fedoriw Kelly Bossenbroek .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska, Omaha, Nebraska, USA

    Paul Paulman

  2. Virginia Beach, Virginia, USA

    Robert Taylor

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this entry

Cite this entry

Bossenbroek, F.K. (2015). Care of the Patient Who Misuses Drugs. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-1-4939-0779-3_67-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_67-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation